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The Link between Environmental 
Toxicant Exposure and 
Endometriosis Re-Examined
Shay M. Freger and Warren G. Foster
Abstract
Endometriosis is widely acknowledged to be an estrogen dependent disease or 
unknown etiology. Recognition that environmental toxicants can bind with and 
activate the estrogen receptor, dysregulate steroid metabolism and, in some cases, 
act as anti-androgenic substances (phthalate esters) has led to proposal that expo-
sure to environmental toxicants are associated with increased risk of endometriosis. 
Since our last review of the subject in 2008, the literature has expanded with several 
epidemiological and biomonitoring studies suggesting a potential association, 
whereas others have been unable to demonstrate a link between exposure and 
enhanced risk. Therefore, we carried out a systematic review and critical appraisal 
of the literature published over the past decade (2009–2019). The majority of 
studies found dealt with exposure to polychlorinated biphenyls (PCBs), dioxins, 
dioxin-like and non-dioxin-like compounds, bisphenol A and phthalate esters. 
Several studies suggest a potential association between exposure to environmental 
toxicants; however, important weaknesses in study design, methodology, and 
analysis together with many contradictory studies weaken confidence in these 
associations. Consequently, we conclude that despite a growing literature, evidence 
for an association between exposure to environmental toxicants and risk of endo-
metriosis remains weak.
Keywords: endometriosis, endocrine disrupters, phthalates, bisphenol A, dioxin, 
estrogenic
1. Introduction
Endometriosis an estrogen dependent disease characterized by ectopic growth 
of endometrial glands and stroma outside of the uterine cavity. It is estimated that 
endometriosis may affect anywhere from 5 to 45% of all women [1]. Although 
retrograde menstruation has become the most widely accepted theory for the devel-
opment of endometriosis [2], it cannot account for endometriosis in distant organs 
such as the lung and brain. Therefore, alternative explanations are sought.
While the cause of endometriosis remains unknown, it most likely arises from 
a multifaceted origin involving the interaction of environment and genetics [3]. 
Among the different hypotheses advanced, a growing body of literature suggests 
that environmental factors including environmental toxicants may play a role 
in the pathophysiology of endometriosis. Lifestyle and medication use point to 
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a role for environmental factors in endometriosis. While alcohol consumption 
and cigarette smoking have been associated with lower endometriosis risk [4], 
developmental exposure to diethylstilbestrol and early life exposure to soy formula 
as well as alcohol consumption in adulthood was linked with an increased risk 
of endometriosis [4, 5]. Support for an environmental toxicant influence on the 
development of endometriosis surged with the report of endometriosis in rhesus 
monkeys treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) [6]. Evidence 
of estrogen mimicry, dysregulation of steroid signaling, and immune modulation 
by environmental toxicants such as the persistent organic pollutants including the 
polychlorinated biphenyls (PCBs), dioxins and dioxin like compounds, pesti-
cides, plasticizers (phthalates and bisphenol A), and some metals has led some to 
hypothesize that human exposure to environmental toxicants may play an impor-
tant role in reproductive health including endometriosis [3]. Although a recent 
systematic review and meta-analysis suggests a possible link between exposure to 
chlorinated organic chemicals and endometriosis [7], we postulate that the role 
of exposure to environmental toxicants in the pathophysiology of endometriosis 
remain uncertain.
Potential associations between exposure to environmental toxicants and 
women with endometriosis have been equivocal with several finding positive asso-
ciations [8–10] whereas others were unable to document an association [11–13]. 
Since our last review of the subject [14–17] numerous studies have emerged 
suggesting a potential link between environmental toxicant exposure and endo-
metriosis [7, 18]. Herein, we describe a systematic review and critical appraisal 
of the recent literature linking exposure to environmental toxicants and endome-
triosis using a modified weight-of-evidence approach to evaluate the strength of 
potential associations.
2. Approach
We conducted a systematic review of the literature between 2008 and present, to 
capture publications since our last review of the subject [14, 17]. An electronic search 
was performed using PubMed and web of science between October and November 
2019. The following search terms were employed: endometriosis and environmen-
tal contaminants, environmental chemicals, environmental toxicants, endocrine 
disrupters, dioxins, polychlorinated biphenyls (PCBs), phthalates, bisphenol A, and 
metals. Inclusion criteria included biomonitoring, epidemiology studies reporting 
chemical concentrations in women with endometriosis compared to a reference pop-
ulation and associated risk. We also included articles describing experimental animal 
studies and in vitro experiments designed to explore the effect of chemical exposure 
on endometriotic lesion survival, growth, and to elucidate potential mechanisms 
relevant to human health. Review papers, meeting summaries, commentaries were 
excluded as were articles written in languages other than English. Article titles were 
downloaded into an Excel spreadsheet and duplicate titles excluded. Articles meeting 
inclusion and exclusion criteria were decided by review of article titles and abstracts 
by both authors. Disagreements were resolved through discussion. Articles meeting 
inclusion criteria were printed in full and read by both authors.
3. Results
Our electronic search of the literature revealed 67 articles from which four 
articles with duplicate titles were excluded (Figure 1). We further excluded six 
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review articles. An additional seven articles were excluded because they either did 
not report chemical concentrations or associated risk for the development of endo-
metriosis. Consequently, 50 articles were retained for full assessment. The largest 
group of articles addressed the association between exposure to chlorinated organic 
compounds including polychlorinated biphenyls (PCBs), dioxins, and dioxin-
like compounds with relatively few studies exploring the link between pesticide 
exposure and endometriosis. Of the chemicals with comparatively short half-lives 
relative to the chlorinated organic compounds and potential to disrupt endocrine 
signaling pathways, several reports linking phthalate esters and bisphenol A with 
endometriosis were found in our search whereas relatively few studies involving 
perfluoroalkyl compounds and metals studies were found.
3.1 Polychlorinated biphenyls (PCBs), dioxin and dioxin-like compounds
PCBs are one of the most widely produced chemicals worldwide, with millions 
of pounds being produced globally over the last decade alone [19] for use a coolants 
in electrical transformers. With 209 possible congeners, PCB toxicity is dependent 
on chemical structure. For example, non-ortho or mono-ortho PCBs are far more 
toxic due to the loss of chlorine atoms on the 2,2′,6,6′ of the benzene rings [20]. Due 
to their diverse structures, PCBs share similar characteristics to estrogen, allowing 
them to have both agonistic and anti-estrogenic activity [21, 22]. PCBs have been 
known to disrupt several organs and tissue types throughout the human body; with 
particular damage to the liver, kidney, and the endocrine system [19]. Our search 
revealed several studies primarily focused on PCB exposure and endometriosis and 
additional studies that explored the link between dioxin and dioxin-like compounds 
and endometriosis (Table 1). Since these compounds are frequently found together 
in human tissues, we will discuss them together.
In a pilot case–control study [24], involving 17 women (10 cases; 7 controls), 
superficial endometriosis was present in 90% of the cases. Of the 29 congeners 
measured in this study, both polychlorinated dibenzofurans (PCDFs) and 
Figure 1. 
Flow diagram summarizing the process of candidate article title identification in our electronic literature 
searches (PubMed and Web of Science) conducted between January 2018 and February 2019, screening, 
and article selection vs. exclusion. The number of articles included vs. excluded and reasons for exclusion are 
indicated.
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Authors Cases vs. 
controls
Exposure investigated Tissue Outcome
Porpora 
et al. [23]
80:78 PCBs 28, 52, 101, 105, 118, 
138, 153, 156, 167, 170, and 
180
Serum Increased risk of 
endometriosis for 
DL-PCB-118 (OR = 3.79; 
95% CI, 1.61–8.91), 
NDL-PCB-138 (OR = 3.78; 
95% CI, 1.60–8.94), 
NDL-PCB-153 (OR = 4.88; 
95% CI, 2.01–11.0), 
NDL-PCB-170 (OR = 3.52; 
95% CI, 1.41–8.79), and 
the sum of DL-PCBs and 
NDL-PCBs (OR = 5.63; 
95% CI, 2.25–14.10) were 
all significant in case versus 
controls.
Cai et al. 
[24]
10:7 PCBs 77, 81, 126, 169, 105, 
114, 118, 123, 156, 157, 167, 
and 189
Serum PCB concentrations were 
higher in peritoneal fluid 
than serum. However, 
the total TEQ LOD and 
dioxin-like PCBs were 
not significantly different 
between women with 
endometriosis and the 
controls.
Trabert 
et al. [25]
251:538 PCBs 18, 28, 44, 49, 52, 66, 
74, 87, 99, 101, 118, 128, 138, 
146, 149, 151, 153, 156, 157, 
167, 170, 172, 177, 178, 180, 
183, 187, 189, 194, 195, 196, 
201, 206, and 209
Serum Several PCB congeners were 
associated with significantly 
lower risk (PCB 170 3rd 
quartile vs. lowest: OR = 0.5; 
95% CI, 0.3–0.9) PCN196 
(3rd quartile vs. lowest: 
OR = 0.4; 95% CI, 0.2–0.7), 
PCB201 (2nd quartile vs. 
lowest: OR = 0.5; 95% CI, 
0.3–0.8; and 3rd quartile vs. 
lowest: OR = 0.4; 95% CI, 
0.2–0.7) but not summed 
values (PCBs 170, 196, 201; 
OR = 1.3, CI 0.8–2.2) and 
estrogenic PCBs (OR = 1.1; 
95% CI, 0.8–1.4).
Ploteau 
et al. [26]
68:45 PCBs 77, 81, 126, 169, 105, 
114, 118, 123, 156, 157, 167, 
189, 28, 47, 99, 100, 153, 154, 
183, 209
Serum, 
omental, 
and 
peritoneal 
adipose
Significant correlations 
for PCB concentrations 
within the three biological 
compartments omental 
versus peritoneal adipose 
tissue were found 
(p < 0.0001). 137.1 vs. 
147.9 ng/g l.w. for sum of 
6 NDL-PCB. Adipose vs. 
serum: WHO-TEQ2005 
DL-PCB = 3.6 pg/g l.w., 
sum of 6 
NDL-PCB = 81.1 ng/g l.w.
Buck-
Louis 
et al. [27]
190:283 
and 
14:113
PCBs: 18, 28, 44, 49, 52, 66, 
74, 87, 99, 101, 114, 118, 128, 
138, 146, 149, 151, 153, 156, 
157, 167, 170, 172, 177, 178, 
180, 183, 187, 189, 194, 195, 
196, 201, 206, and 209.
Serum 
and 
omental 
fat
Higher concentrations in 
omental fat than serum. 
PCB-74, and PCB-156 in fat 
were inversely associated 
with the odds of an 
endometriosis.
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dioxin-like (DL) -PCBs showed no significant difference between the case and con-
trol [24]. However, both were elevated in peritoneal fluid relative to the serum, with 
the reverse seen in polychlorinated dibenzo-p-dioxins (PCDDs) [24]. Both PCDDs 
and PCDFs in peritoneal fluid were significantly associated with an increased risk 
of endometriosis [24]. Although a potential association was found, the small sample 
size, the authors did not adjust for other factors such as age that have previously 
been shown to affect endometriosis risk. Hence, confidence in the findings from 
this pilot study is low. In contrast, results of a case–control study [23] of 158 Italian 
women (80 cases; 78 controls), revealed that both non-dioxin-like (NDL)-PCBs 
and DL-PCBs levels were significantly elevated in women with laparoscopically 
and histologically confirmed endometriosis. An increased risk of endometriosis 
was found for DL-PCBs (PCB-118 [odds ratio (OR) = 3.79; 95% confidence interval 
(CI), 1.61–8.91], and NDL-PCBs including PCB-138 (OR = 3.78; 95% CI, 1.60–8.94), 
PCB-153 (OR = 4.88; 95% CI, 2.01–11.0), PCB-170 (OR = 3.52; 95% CI, 1.41–8.79), 
and the sum of DL-PCBs and NDL-PCBs (OR = 5.63; 95% CI, 2.25–14.10)). No 
Authors Cases vs. 
controls
Exposure investigated Tissue Outcome
Martínez-
Zamora 
et al. [28]
30:30 2,3,7,8-TCDD, 1,2,7,8-
PeCDD, 1,2,3,4,7,8-HxCDD, 
1,2,3,6,7,8-HxCDD, 
1,2,3,7,8,9-HxCDD, 
1,2,3,4,6,7,8-HpCDD, 
2,3,7,8-TCDF, 1,2,3,7,8-
PeCDF, 2,3,4,7,8-PeCDF, 
1,2,3,4,7,8-HxCDF,1,2,3,6,7,8-
HxCDF,2,3,4,6,7,8-HxCDF, 
1,2,3,7,8,9-HxCDF, 
1,2,3,4,6,7,8-HpCDF, 
1,2,3,4,7,8,9-HpCDF, OCDF
Adipose 
tissue 
from the 
omentum
Dioxins and DL-PCBs 
were significantly higher 
in patients with deep 
infiltrating endometriosis; 
TCDD, PeCDD, PeCDF 
were the most significant 
p < 0.01 for each compound. 
PCB-126 (PCB-114 p < 0.05; 
PCB-156 p < 0.05; PCB-189 
p = 0.04; PCB-126 p < 0.01).
Simsa 
et al. [29]
96:106 DLCs not specified Plasma DLC concentrations 
were marginally 
higher in patients with 
endometriosis (22.3±9.3 pg 
vs. 20.5±10.8 pg) and higher 
plasma levels of DLC were 
linked to a higher risk of 
endometriosis (aOR = 2.44; 
95% CI 1.04–5.70; p = 0.04) 
adjusted for age. Moderate–
severe endometriosis cases 
only (OR = 3.01; 95% CI 
1.06–9.04; p = 0.03)
Vichi 
et al. [30]
181:162 PCBs 118, 153, 138, 170, 180, 
and total PCBs
Serum With the presence of the 
GSTP1 wild type genotype, 
medium-high levels of PCB 
153, high levels of PCB 
180 and total PCBS were 
significantly associated 
with endometriosis risk 
(OR = 6.00; 95% CI, 
1.88–19.18 and OR = 9.08; 
95% CI, 2.14–44.4, 
respectively).
Table 1. 
Summary of exposures and outcomes from biomonitoring studies designed to quantify the concentration of 
polychlorinated biphenyl congeners, dioxins, dioxin-like compounds (DLCs) and non-dioxin-like compounds 
(NDL) in women with endometriosis compared to healthy controls.
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significant associations were observed with respect to hexachlorobenzene (HCB) 
or to the sum of polychlorinated dibenzodioxins (PCDDs), polychlorinated 
dibenzofurans (PCDFs), and DL-PCBs expressed as total toxic equivalent quo-
tients (TEQs). PCB-101, PCB-156, and PCB-170 were all shown to be statistically 
elevated, with PCB-52, PCB-118, PCB-138, PCB-153, and PCB-180 showing a highly 
significant difference. All four stages and endometriosis implant localizations (peri-
toneal, deep, or ovarian) were analyzed, with no significant differences detected. 
However, the lack of adjustment for potential confounding and failure to account 
for multiple comparisons are important limitations of this study. IN another study 
[29], DLC concentrations were quantified in plasma samples using the dioxin-
responsive chemical-activated luciferase expression bioassay (CALUX). Blood 
samples were collected prior to laparoscopic surgery from women with endometrio-
sis (n = 96) and control patients with a normal pelvis (n = 106). A marginal increase 
in DLC compound concentrations in endometriosis patients relative to controls 
(22.3 ± 9.3 pg, versus 20.5 ± 10.8 pg CALUX-TEQ/g lipid) was reported [29]. After 
adjusting plasma concentrations for age only, an increased risk for endometriosis 
was demonstrated for high concentrations of DLC (OR = 2.44; 95% CI 1.04–5.70, 
p = 0.04) and when considering moderate to severe endometriosis (OR = 3.01; 95% 
CI 1.06–9.04, p = 0.03). While the authors adjusted for age, adjustment for BMI, 
parity, and breast feeding was not undertaken. Thus, these results although sugges-
tive must be interpreted with caution.
While several studies have provided evidence of a potential link significant 
associations between women with endometriosis and PCB levels could not be 
demonstrated by other investigators [25, 28, 31]. No significant association between 
PCBs and endometriosis risk was found in a study of 789 patients (251 cases; 538 
controls); with 20 PCB congers measured in serum from surgically confirmed cases 
[25]. While the odds ratios (ORs) for several PCB congeners did show significant 
levels above and below the null; however, there was no specific pattern associated 
with endometriosis risk. Several PCBs were quantified in the serum of 473 women 
in an operative cohort (190 cases; 283 controls) and 127 patients from a general 
population cohort (14 cases; 113 controls), using omental fat in the operative cohort 
and serum in both [31]. Results were adjusted for confounding variables such as 
age, BMI, breast-feeding, cotinine, and lipids. Among the 35 PCB congers analyzed, 
geometric mean serum PCB levels were found to be inversely related in terms of 
risk in the operative cohort, with the opposite seen in the population cohort [31]. 
A similar relationship can be seen in omental fat, with sum PCB levels showing 
significantly higher levels in the non-endometriosis patients relative to the controls. 
Limitations of this study include the small number of women with endometriosis in 
the case population (only 11% of women had endometriosis), possible bias through 
the use of telephone directories, and use of controls without surgical confirmation 
of absence of disease suggest that results be interpreted with caution. The relation-
ship between exposure to DLCs and deep infiltrating endometriosis (DIE) was 
explored in a case–control study of 30 cases and 30 controls [28]. Disease status 
was determined by clinical examination, magnetic resonance imaging (MRI), and 
transvaginal ultrasonography (TVUS), whereas the control population underwent 
laparoscopic surgery for adnexal benign gynecological disease. DLCs were analyzed 
omentum adipose tissue in both groups. The results suggest a significant increase 
of both dioxins and PCBs relative to the control, with the most toxic forms showing 
a significant difference (2,3,7,8-TCDD and 1,2,3,7,8-pentachlorodibenzo-p-dioxin 
[1,2,3,7,8-PeCDD]; p < 0.01) [28]. Furthermore, 2,3,4,7,8-PeCDF was also signifi-
cantly higher and four of the most toxic PCB congeners (PCB 144, 156, 189, 126) 
had toxic equivalence values (TEQ ) that were statistically higher in DIE patients 
[28]. However, no differences were seen when the data were adjusted for age, breast 
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feeding, and BMI. Limitations of this study include small sample size, and homoge-
neity of the sample population [28].
A biomonitoring study conducted in France [26], measured the concentra-
tions of PCBs in serum, peritoneal and omental adipose tissue of 113 adult French 
women with deep infiltrating endometriosis (DIE) (45 controls, 68 cases). There 
was a significant difference between omental versus peritoneal adipose tissue PCB 
concentrations (p < 0.0001). Similar trends were seen is peritoneal adipose tissue 
versus serum levels, with PCBs showing the highest level of significance in terms of 
concentration differences.
Potential gene–environment interaction among women with endometriosis was 
explored [30]. Specifically, the relationship between glutathione transferase (GST) 
gene polymorphisms PCB concentrations in a study of 343 Italian women (181 
cases; 162 controls). Ability glutathione enzymes to regulate oxidative free radicals 
and thus oxidative stress and therefore genetic polymorphisms may influence 
tissue capacity to manage the damaging effects oxidative stress, in turn influencing 
disease susceptibility. No significant difference in genotype distribution (GSTM1, 
GSTA1, and GSTP1) between case and control patients could be elicited [30]. 
However, the GSTP1 wild-type with medium-high blood levels of PCB153, high 
levels of PCB180, or total PCB levels, showed a significant increase in potential risk, 
while GSTT1 null was negatively associated with the disease [30]. The potential 
association between five microsatellites and 28 single nucleotide polymorphisms 
among 10 dioxin detoxification genes (aryl hydrocarbon receptor (AhR), AHRR, 
ARNT, CYP1A1, CYP2E1, EPHX1, GSTM1, GSTP1, GSTT1, NAT2) was examined 
in 242 women (100 case; 143 control) from Japan [32]. Accounting for disease stages 
I-IV, BMI, and smoking, no significant association was seen between the polymor-
phisms and the contribution to the etiology of endometriosis. Taken together, these 
data suggest that genetic polymorphisms in detoxification enzymes do not modulate 
endometriosis risk.
Establishing a link between exposure to environmental toxicants and endome-
triosis using epidemiology and biomonitoring is difficult owing to challenges in 
diagnosis of endometriosis [33], lengthy diagnostic delays [34], and high prevalence 
of endometriosis in asymptomatic women [1] and thus the potential for misclas-
sification error is high. Therefore, animal studies have been employed to better 
understand the potential hazard posed between toxicant exposure and endome-
triosis. Developmental exposure of mice to TCDD induced a progesterone-resistant 
phenotype in adult animals that persisted across generations [35]. Results of this 
study suggest that TCDD induced activation of the aryl hydrocarbon signaling 
pathway induces dysregulation of expression of tissue remodeling enzymes, and 
contributes to the inflammatory responses, cell migration, and proliferation seen in 
endometriosis patients. These data are supported by prior animal studies demon-
strating PCB and dioxin effects in animal models of endometriosis [36–38].
Tissue culture studies have been employed to elucidate potentially important 
toxicant regulated mechanisms. PCBs have been linked to an increased estradiol 
synthesis and creating an inflammatory milieu through the production of inter-
leukin (IL)-6 and IL-8 [39]. Primary cultures of endometrial stromal cells (ESCs) 
were treated with both DL-PCBs and NDL-PCBs. Dioxin-like CB126 treatment 
increased 17β-estradiol (E2) biosynthesis in a dose dependent manner. CB126 
exposure also increased 17β-hydroxysteroid dehydrogenase 7 (HSD17B7) as well as 
decreased methylation of the HSD17B7 promoter leading to an increase in expres-
sion. Inflammatory markers were also elevated in cultured endometrial stromal 
cells. Increased inflammation and E2 synthesis were demonstrated in a mouse 
model of endometriosis [39]. Although PCB has shown to increase E2 biosynthesis, 
combining 17β-Estradiol with TCDD showed a synergistic effect and induces M2 
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activation with macrophages co-cultured with ESCs. STAT3 and P38 phosphory-
lation in macrophages were also increased differentiation of M2 macrophages, 
leading to an inflammatory milieu [40]. Several studies also analyzed the impact 
of TCDD exposure on progesterone-dependent mechanisms. TCDD was found 
to induce cannabinoid receptor type 1 CB1-R mRNA expression in endometrial 
stromal cells and steroid-induced expression of the gene was inhibited. Through 
the use of tissue obtained from women with and without endometriosis, TCDD 
treatment-induced dysregulation of cannabinoid signaling, immune cell migration 
into the endometrium during embryo uterine attachment [41] and thus we propose 
could be an important mechanism in the pathophysiology of endometriosis. PCB 
was also seen to activate endogenous aryl hydrocarbon receptor (AhR) signal-
ing pathway in immortalized human telomerase reverse transcriptase (hTERT) 
endometrial epithelial cell (hTERT-EEC), specific to time, concentration, and 
congener. The changes induced were modulated by changes in estrogen levels, 
in turn increasing cell migration by hTERT-EEC. Proteomic analysis also identi-
fied cell stress responses and metabolism markers (such as heat shock proteins 
(HSP) 27 and HSP 70) [42]. These proteins are both critical markers for the 
regulation of apoptosis and cellular stress response pathways. In another study 
[43] primary cultures of ESCs from both case and control patients showed that 
PCB-104 exposure affects cell migration, invasion and resultant gene expression. 
Treatments induced a significant increase in cell migration and invasion of ESCs. 
Enzyme-linked immunosorbent assays showed a time and dose dependent increase 
in matrix metalloproteinase 3 (MMP-3) and MMP-10 protein in ESCs, whereas 
MMP-2, MMP-9, TIMP-2, E-cadherin, Snail and Slug did not. MMP-3 contributes 
to the breakdown of the extracellular matrix and promotes tissue remodeling and 
migration [43]. The results from this study suggest that PCB-104 increased migra-
tion and invasion of ESCs through increasing MMP-3 and MMP-10 [43]. Taken 
together, results from tissue culture studies elucidate PCB and dioxin induced 
dysregulation of mechanisms potentially important in the pathophysiology of 
endometriosis.
In summary, several studies demonstrated a potential association between 
exposure to PCBs, dioxins, and dioxin-like compounds and increased risk of endo-
metriosis; however, important study limitations decrease confidence in these study 
findings. Moreover, several studies were unable to evoke evidence of an association 
between exposure to these toxicants. While, animal studies are few, results from 
these studies provide evidence of biological plausibility. Results of tissue culture 
studies also provide evidence that PCBs and dioxins adversely affect mechanistic 
pathways important in the pathophysiology of endometriosis although the effective 
concentrations exceed human exposure. Consequently, we suggest that there is 
weak evidence linking exposure to PCBs and dioxin and DL-PCBs in the patho-
physiology of endometriosis.
3.2 Pesticides
Chlorinated organic pesticides (COPs) resist degradation in the environment, 
are lipophilic and thus bioaccumulate in adipose tissues, and concentrations are 
biomagnified with increasing trophic level. Moreover, COPs are able to travel 
long distances and remain stable for several decades in the environment, and thus 
widespread human exposure to these chemicals has frequently been documented. 
Despite widespread human exposure, the relationship between pesticides and 
endometriosis risk in general are equivocal.
The concentrations of six COP levels were measured with gas chromatogra-
phy and electron-capture, in blood samples of laparoscopically confirmed cases 
9The Link between Environmental Toxicant Exposure and Endometriosis Re-Examined
DOI: http://dx.doi.org/10.5772/intechopen.91002
of endometriosis [44]. Results showed that aromatic fungicides had a five-fold 
increase in risk (aOR = 5.3; 95% CI, 1.2–23.6) when comparing the highest and 
lowest tertile after adjusting for smoking and serum lipids [44]. Chlordane (t-non-
achlor) (aOR = 4.6; 95% CI, 0.5–41.6) and HCB (aOR = 6.4; 95% CI, 1.0–42.8) 
showed a similar trend [44]. Aldrin, β-hexachlorocyclohexane (β-BHC) and mirex 
also had increased ORs; however, few women had concentrations above the limit 
of detection preventing further analysis. Two other studies yielded similar results. 
Specifically, hexachlorocyclohexane (HCH) was associated with an increased risk 
of endometriosis in a large study with 248 surgically confirmed endometriosis 
cases and 538 controls [45]. β-HCH concentrations were significantly elevated in 
the serum (third vs. lowest quartile: OR = 1.7; 95% CI: 1.0–2.8; highest vs. low-
est quartile OR = 1.3; 95% CI: 0.8–2.4), as well as for mirex (highest vs. lowest 
category: OR = 1.5; 95% CI: 1.0–2.2). The results were adjusted for participant age, 
reference date year, serum lipids, education, race/ethnicity, smoking, and alcohol 
intake. Although trends were seen throughout multiple forms of endometriosis, 
the strongest association was seen in women with ovarian endometriosis. Similarly, 
γ-hexachlorocyclohexane (γ-HCH) had a significant association with endometriosis 
risk (adjusted OR (AOR) for age, body mass index, breast-feeding conditional on 
parity, cotinine, and lipids = 1.27; 95% CI: 1.01–1.59) [31]. Although these studies 
provide evidence for a link between exposure to different pesticides and increased 
risk of endometriosis, there are several limitations to note. In particular, while the 
authors adjusted their data for some potential confounding variables none appeared 
to adjust for BMI. Moreover, since multiple pesticides were quantified in each 
study, correction for multiple comparisons would add confidence to the findings 
and exclude the potential for type I error. Furthermore, the lack of a dose–response 
relationship [45] suggests that chance discovery cannot be excluded.
We found no recent animal studies and only one in vitro study was found. HCB 
treatment enhanced MMP-2 and MMP-9 activities in human endometrial stromal 
cell line T-HESC, primary cultures of Human Uterine Fibroblast (HUF), and ESCs 
[46]. Specifically, MMP-2 was only elevated in ESCs, whereas MMP-9 was elevated 
in all models. An increase in COX-2 and prostaglandin receptor-4 expression, 
prostaglandin E2 secretion and the c-Src kinase activation in T-HESC was also seen 
after HCB exposure. The results suggest that HCB may promote inflammation and 
invasion parameters through regulation of the AhR pathway.
In summary, the epidemiological and biomonitoring studies suggest a potential 
association between exposure to chlorinated organic pesticides and increased risk 
of endometriosis; however, study limitations cannot exclude chance discovery 
owing to multiple comparisons, failure to adequately adjust for important con-
founders and lack of a dose–response relationship all weaken confidence in the 
link between COP exposure and endometriosis risk. A single tissue culture animal 
experiment conducted within the search window suggests that it is biologically 
plausible for COPs to promote endometriosis risk. Consequently, we suggest weak 
evidence linking exposure to COPs and endometriosis.
3.3 Perfluoroalkyl and polyfluoroalkyl substances
Perfluoroalkyl substances are a rather unique group of compounds due to their 
seemingly harmless properties. However, over the last decade, perfluoroalkyl and 
polyfluoroalkyl substances have been detected in blood and urine across the globe 
[47, 48]. Compromised of carbon-fluorine atoms, this extremely strong bond forms 
stable compounds that are used in clothing, cookware, carpets, and other common 
household items. Exposure to these compounds has been linked to adverse effects 
on metabolism, immune function, and fertility [49–51].
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In a case–control study [27], nine perfluorochemicals (PFCs) were measured 
in the blood of study participants by liquid chromatography–tandem mass spec-
trometry. Surgical visualization was used to confirm endometriosis in the operative 
population and MRI was used to confirm the absence of endometriosis in the con-
trol population. Both perfluorooctanoic acid (PFOA; OR = 1.89 [95% CI = 1.17–3.06]) 
and perfluorononanoic acid (PFNA) (2.20 [1.02–4.75]) were seen to be associ-
ated with endometriosis risk, where results were only moderately changed when 
adjusted for fecundity [27]. Patients with more severe stages of endometriosis 
(Stages III and IV) showed a higher concentration of perfluorooctane sulfonic acid 
(1.86 [1.05–3.30]) and PFOA (2.58 [1.18–5.64]) in their blood compared to controls 
[27]. Although this study shows a significant association between PFC exposure 
with an apparent dose response, there are a number of limitations to consider. First 
assignments of healthy study participants to the control population using MRI 
alone to exclude asymptomatic endometriosis cannot exclude women with endome-
triosis. Undiagnosed endometriosis was found in 45.3% of asymptomatic women 
undergoing laparoscopies for benign conditions [1] and thus the potential for mis-
classification error in this study weakens confidence in the purported association. 
Finally, circulating concentration of PFCs from the NHANES (2003–2006) study 
was compared in 753 women with self-reported diagnosis compared to healthy 
women without a diagnosis of endometriosis [52]. Results from this study showed 
that PFNA, PFOA, and perfluorooctane sulfonate (PFOS) were significantly higher 
among women with endometriosis compared to the control population. Women 
in the referent population of this study were significantly younger, non-Hispanic 
white, had more than one menstrual period in the last year and reported to be 
pregnant at the time of the exam. Furthermore, use of self-reported diagnosis of 
endometriosis may introduce group assignment bias and thus, these data must be 
interpreted with caution.
The data linking exposure to Perfluoroalkyl substances and endometriosis are 
limited to the results of two biomonitoring studies. Although the results suggest 
that women with endometriosis have exposure to Perfluoroalkyl substances, any 
potential association with endometriosis is weak owing to limitations of these stud-
ies and absence of experimental animal studies or mechanistic experiments.
3.4 Bisphenol A (BPA)
A monomeric compound, bisphenol A (BPA) is used to polymerize plastics 
and can be found in common household items such as toilet paper, water bottles, 
the lining of tin cans, cash register receipts, dental sealants, and building supplies 
[53]. With over a million tons of BPA being used in the United States alone, BPA 
has become ubiquitous in the environment leading to widespread human exposure. 
BPA is able to bind to both estrogen receptors (Esr1 and Esr2), activate the estrogen 
signaling cascade and thus is considered a xenoestrogen [54]. Estrogenic capacity 
has led some to postulate that BPA exposure may play a role in the pathophysiology 
of endometriosis (Table 2).
A population-based case–control study [56], analyzed the urine from 143 
women with confirmed or suspected endometriosis (cases) and 287 healthy 
controls. Urinary creatinine concentrations, age, reference year, as well as both 
ovarian and non-ovarian pelvic endometriosis were taken into account. Overall, the 
urinary BPA concentrations in cases did not differ from the control group. However, 
unconditional logistic regression analysis revealed that the second versus lowest 
quartile and third versus lowest quartile had increased adjusted odds ratio (aOR 
3.0; 95% CI: 1.2–7.3 and aOR 3.0; 95% CI: 1.1–7.6) for higher BPA concentrations in 
women with non-ovarian pelvic endometriosis; however, there was no association 
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between urine BPA concentrations and ovarian endometriosis. Moreover, there was 
no relationship between the highest urine concentrations of BPA and endometriosis 
overall as well as for non-ovarian pelvic endometriosis and ovarian endometriosis. 
Furthermore, the lack of a dose–response relationship with increasing urine con-
centrations of BPA weakens confidence in the potential link between BPA exposure 
and endometriosis risk.
Results of biomonitoring studies revealed that mean BPA concentrations in the 
plasma of infertile women with endometriosis (n = 11), polycystic ovarian syn-
drome (PCOS, n = 31) and PCOS plus endometriosis (n = 3) combined (4.66 ± 3.52, 
95% CI; 3.60–5.72 ng/ml) were significantly greater than in a control population 
(n = 34) of healthy fertile women (2.64 ± 3.99, 95% CI; 1.24–4.03 ng/ml) [59]. In 
women who reported a diagnosis of endometriosis, the mean ± (SD) concentration 
of BPA was 4.59 ± 1.22 ng/ml (range < LOQ – 5.31 ng/ml). Moreover, BPA concen-
trations were quantifiable in only 3% of study participants and comparisons with 
the fertile controls was not reported. Given the ubiquitous nature of BPA, the low 
detection frequency in this study is rather surprising and thus we interpret these 
findings with caution. The small sample size, self-reported diagnosis of endome-
triosis and associated potential for misclassification error are important limitations 
of this study. Results of a much larger cross-sectional study of 166 Japanese women 
[58], showed no significant difference in BPA levels in the urine. BPA concentra-
tions were non-significantly (p = 0.24) greater in women with endometriosis stage 
0–I (median = 0.74 μg/g after adjusting to creatinine levels), whereas women with 
stages II-IV endometriosis had a median concentration of 0.93 μg/g creatinine [58]. 
BPA levels measured in the sera from healthy fertile (n = 11) and endometriotic 
women (n = 58) found that both BPA and bisphenol B (BPB) levels were detectable 
Authors Cases vs. 
controls
Exposure 
Investigated
Tissue Outcome
Simonelli 
et al. [55]
68:60 BPA Urine and 
peritoneal 
fluid
Urinary BPA levels were found in all 
analyzed samples; with a statistically 
significant difference between patients and 
controls. Urinary BPA concentrations were 
significantly greater (p = 0.001) in women 
with endometriosis compared to the control 
group.
Upson 
et al. [56]
143:287 BPA Urine No statistically significant association 
between total urinary BPA concentrations 
and endometriosis overall. However, 
significant results were seen in urine 
in relation to non-ovarian pelvic 
endometriosis (2nd quartile vs. lowest 
quartile: OR = 3.0; 95% CI: 1.2–7.3 and 
3rd vs. lowest quartile: OR = 3.0; 95% CI: 
1.1–7.6), but not ovarian endometriosis.
Cobellis 
et al. [57]
58:11 BPA and 
BPB
Serum BPA was found in 51.7% and BPB was 
found in sera 27.6% but either could not be 
detected in all the control cases. Suggests 
an association between at least one of the 
compound endometriosis risk.
Itoh 
et al. [58]
166 
infertile 
women
BPA Urine No significant (p = 0.24) association 
of endometriosis with urinary BPA 
concentration.
Table 2. 
Summary of exposures and outcomes in epidemiological studies designed to investigate the association between 
Bisphenol A (BPA) exposure and endometriosis.
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in 51.7% and 27.6% of cases, respectively whereas the control patients showed a 
complete absence of both compounds [57]. Recently, urinary concentrations of BPA 
were significantly greater in women (n = 68) with endometriosis (1.17–12.68 pg/μl)  
compared to a control population (n = 60) (1.28–2.35 pg/μl) [55]. Finally, BPA has 
a short half-life and the measures in women with a diagnosis of endometriosis are 
temporally disconnected from the onset of disease which may have originated years 
earlier in time. The interval between onset of symptoms and diagnosis ranges from 
6 to 12 years [34] and thus exposure measurements made after diagnosis are dif-
ficult to link with the development of endometriosis. Therefore, reverse causation 
cannot be excluded as a potential explanation for differences in circulating concen-
trations of the toxicants measured.
In an animal study [60], BPA and bisphenol AF (BPAF) affected endometriosis 
lesion development in ovariectomized and hormonally intact mice specific to dose 
and hormonal status of the host mouse. Minced uterine tissue was injected into 
the peritoneal cavity of host mice. In this study, BPA treatment disrupted ovarian 
steroidogenic pathways resulting in lower progesterone levels and higher atretic 
oocyte numbers [60]. BPAF and BPA had higher epithelial proliferation scores, 
although this was only significant in the highest dose of 900 ppm. Both compounds 
mimicked estrogen, with BPAF having a stronger effect than estrogen [60]. Taken 
together, these data suggest that BPA and related compounds can affect mecha-
nisms important in the pathophysiology of endometriosis. However, the concen-
trations of BPA needed to achieve these effects are higher than human exposure 
and thus are unlikely to be relevant at the concentrations of BPA measured in the 
general human population in contemporary studies.
Results of a tissue culture experiments demonstrated that BPA treatment 
arrested human ESCs at the G2/M phase of the cell cycle, allowing for cell migra-
tion. Progesterone amplifying receptors such as insulin growth factor binding 
protein 1 and prolactin were also increased in response to BPA treatment [61]. These 
results suggest that BPA exposure could modulate endometrial stromal cells func-
tion; however, the effective concentrations exceed human exposure. Consequently, 
ambiguous study results from biomonitoring studies and lack of animal studies 
suggests a lack of association between BPA exposure and risk of endometriosis.
3.5 Phthalate esters
Phthalate esters are used as a softener in polyvinyl chloride plastics to make 
plastics flexible and can be found in products such as cosmetics, building materials, 
and in medical equipment such as intravenous bags, tubing and rubber stoppers in 
syringes and blood collection tubes. Phthalates leach from finished products leading 
to ubiquitous human exposure [62, 63]. Exposure to phthalate esters has been 
linked with decreased circulating testosterone [64] and animal experiments have 
shown that phthalates are competitive antagonists of the androgen receptor that 
displace testosterone from the receptor increasing its availability for conversion to 
estrogens via aromatase [65]. Therefore, it is postulated that exposure to phthalates 
could be associated with increased risk of endometriosis (Table 3).
A large case–control study [67], examined 626 women (495 cases; 131 controls) 
from 14 clinical centers. Study participants in both groups had a laparoscopy or 
a pelvic MRI to diagnose the presence of endometriosis. Among the 14 phthalate 
metabolites, mono-n-butyl phthalate, mono-[(2-carboxymethyl) hexyl] phthalate, 
mono (2-ethyl-5-carboxyphentyl) phthalate, mono (2-ethylhexyl) phthalate, mono 
(2-ethyl-5-hydroxyhexyl) phthalate, and mono (2-ethyl-5-oxohexyl), all showed 
two-fold significant increase in the odds of diagnosis. Results were adjusted for age, 
BMI, and creatinine. Depending on the method of diagnosis, monooctyl phthalate 
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was restricted to surgical diagnosis of endometriosis with histological confirma-
tion, whereas mono (2-ethylhexyl) phthalate was restricted to surgical diagnosis 
alone. However potential limitations may arise through adding concentrations as 
mECPP, mEHHP, mEOHP where all are metabolites of DEHP that were elevated 
in the operative cohort. Yet when summing DEHP metabolites (mECPP, mCMHP, 
mEHHP, mEOHP, and mEHP), there is a higher odds of endometriosis in the con-
trol population cohort. A further limitation is the lack of adjustment for multiple 
comparisons and thus chance discovery cannot be excluded. A large study from the 
National Health and Nutrition Examination Survey (NHANES, 1999–2004), exam-
ined phthalate levels in 1227 women, with a self-reported history of endometriosis 
Authors Cases vs. 
controls
Exposure 
investigated
Tissue Outcome
Pednekar 
et al. [59]
34:45 BPA, MMP, MBzP, 
MEHP, MEHHP, 
MiBP-d4 and 
BPA-d6
Plasma Significantly higher plasma 
concentrations of MBzP (95% CI; 
11.69–28.12 versus 3.34–8.10), BPA 
(95% CI; 3.60–5.72 versus 1.24–4.03), 
and MEHHP (95% CI; 5.10–8.43 versus 
0.58–2.85).
Nazir 
et al. [66]
50: 50 DEHP Serum The mean (± SD) DEHP concentration 
in cases was 65.29 ± 21.69 ng/ml and 
undetectable in controls. An increasing 
trend was seen across stages (I-IV).
Buck 
Louis 
et al. [67]
495:131 DEHP, mECPP, 
mCMHP, mEOHP, 
mEHHP, mEHP, 
mCPP, mMP, 
miBP, mBP, 
mCHP, mBzP, 
mNP, and mOP,
Urine MBP, mCMHP, mECPP, mEHP, mEHHP, 
mEOHP, all showed a two-fold significant 
increase in the odds of diagnosis.
Huang 
et al. [68]
28: 29 MBP Urine Increase in urinary mono-n-butyl 
phthalate (94.1 versus 58.0 microg/g 
creatinine, p < 0.05) in women with 
endometriosis compared to controls.
Itoh et al. 
(2009)
57:80 MEP, MBP, MBzP, 
MEHP, mEOHP, 
and MEHHP
Urine No significant (p = 0.23–0.90) association 
between endometriosis and any urinary 
creatinine-adjusted phthalate measured.
Weuve 
et al. [69]
n = 1227 MEHP, BMP, MEP, 
and MBzP
Urine Positive associations for MBP (OR = 1.36; 
95% CI, 0.77–2.41) for the highest versus 
lowest three quartiles, and inverse 
associations for MEHP in relation to 
endometriosis (OR = 0.44; 95% CI, 
0.19–1.02)
Huang 
et al. [70]
44:69 MMP, MEP, MnBP, 
MBzP, MEHP, 
5oxo-MEHP, 
5OH-MEHP
Urine Marginally increased level of urinary 
MEHP only.
Upson 
et al. 
[45, 71]
92:195 MEHP, MEHHP, 
MEOHP, MECPP, 
MBzP, MEP, MiBP, 
MnBP
Urine Greater urinary concentrations of MBzP 
and MEP in the urine of women with 
endometriosis compared to controls. 
Strong inverse association between 
urinary MEHP and endometriosis risk 
(aOR 0.3, 95% CI: 0.1–0.7).
Table 3. 
Summary of exposures and outcomes in epidemiological studies designed to investigate the association between 
phthalate exposure and endometriosis.
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and uterine leiomyomata. MEHP, monobutyl phthalate (MBP), monoethyl phthal-
ate (MEP), and MBzP levels were measured in patients with each disease as well 
as patients that reported both [69]. Comparing the highest versus lowest three 
quartiles of urinary phthalate levels, MBP had an OR of 1.36 (95% CI, 0.77–2.41), 
MEHP was 0.44 (95% CI, 0.19–1.02), with no association for MEP and MBzP in 
endometriosis patients. Significantly higher plasma concentration of DBP which is 
broken down into MBP was also seen [69]. However, the use of self-reported cases 
may be unreliable. Contrary to the NHANES study, an increased endometriosis risk 
with an increase in urinary MBzP and MEP was described although the results were 
not significant [71]. Moreover, an inverse relationship between endometriosis risk 
and urinary MEHP was found (OR = 0.3; 95% CI = 0.1–0.7) and an inverse relation-
ship was also suggested for DEHP, MEHHP, mono-(2-ethyl-5-oxohexyl) phthalate 
(MEOHP) and ΣDEHP. Therefore, a compelling link between phthalate exposure 
and endometriosis has not been established.
Results of several biomonitoring studies have documented higher concentra-
tions of phthalate metabolites in the urine of women with endometriosis compared 
to a reference population. Plasma concentrations of mono-methyl phthalate 
(MMP), mono-benzyl phthalate (MBzP), mono-2-ethylhexyl phthalate (MEHP) 
and mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) were recently quantified 
by gas chromatography–mass spectrometry in infertile women with endometriosis 
(n = 11), polycystic ovarian syndrome (PCOS, n = 31) and PCOS plus endome-
triosis (n = 3) and 34 fertile women without evidence of gynecological disorders 
[59]. Overall, the mean (± SD) concentrations (ng/ml) of MBzP (19.9 ± 27.3 95% 
CI;11.69–28.12) and MEHHP (6.76 ± 5.54, 95% CI; 5.10–8.43) were significantly 
higher in infertile women compared to fertile women (5.72 ± 6.82, 95% CI; 
3.34–8.10 and 1.71 ± 3.24, 0.58–2.85; respectively), whereas no differences were 
detected between groups for MMP and MEHP. The mean concentrations of MBzP 
and MEHHP in women with endometriosis were 40.9 ± 51.4 (range < LOQ – 116.5) 
and 5.43 ± 5.53 ng/ml (range < LOQ – 14.76), respectively. However, only 4–5% of 
women with endometriosis had concentrations of MBzP and MEHHP above the 
LOQ. Study participants were assigned to groups based upon self-reports of gyne-
cological diagnoses which is open to misclassification error. In addition, the small 
sample size overall together with the limited number of study participants with 
quantifiable concentrations of phthalates are important limitations of this study.
Recently, differences in serum DEHP concentrations were found between 
women with endometriosis and control patients using high-performance liquid 
chromatography [66]. The mean ± SD concentration of DEHP in cases (n = 50) 
was 65.3 ± 21.7 ng/ml, whereas it was undetectable in the controls. Among the 
four stages of the disease, women with endometriosis showed a linear increase in 
DEHP concentration with more advanced stages, although the sample size for stage 
I was n = 1. Age groups did not impact DEHP serum levels. Controversy remains, 
as DEHP is broken down by glutathione S-transferase and P450 enzyme, which 
has been reported to be compromised in endometriosis patients [72]. This may 
explain the difference in serum concentration, as the control patients are able to 
metabolize DEHP into metabolites which were not recorded. A further weakness 
of this study is the measurement of DEHP in the serum rather than metabolites in 
either the serum or urine and thus the potential for sample contamination cannot 
be discounted.
A group from Taiwan investigated the association between GSTM1 poly-
morphisms and phthalates in adenomyosis, leiomyoma and endometriosis [68]. 
Although no relationship between the gene and the disease was found, there was an 
increase in urinary mono-n-butyl phthalate (94.1 versus 58.0 microg/g creatinine, 
p < 0.05) among the 28 women with endometriosis relative to the 29 controls. 
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In a subsequent study [70], the potential relationship between polymorphisms of 
CYP17A1 and phthalate exposure was explored in women with leiomyoma (fibroids, 
n = 36), endometriosis or adenomyosis (n = 44) and healthy controls (n = 69). 
However, only a marginally increased level of urinary MEHP was found in patients 
with endometriosis or adenomyosis [70].
Our search failed to identify any experimental animal studies and only two 
mechanistic studies were located. MMP-2 and 9 activities, cellular invasiveness, 
Erk phosphorylation, and p21-activated kinase 4 expression (PAK4) were increased 
in endometrial stromal cell cultures exposed to DEHP [73]. All five significantly 
elevated markers play a role in cellular division, actin cytoskeletal dynamics, motil-
ity, cell survival, and immune defense [73, 74]. Another study found that DEHP 
treatment increased ESC reactive oxygen species (ROS) generation and decreased 
expression of superoxide dismutase (SOD), glutathione peroxidase (GPX), heme 
oxygenase (HO), and catalase (CAT). p-ERK/p-p38 and NF-κB were also increased 
[75]. This provides a potential explanation for the decreased expression of antioxi-
dant enzymes and increased ROS. Lastly, Esr1 expression was also increase propor-
tional to dose [75].
In summary, while several studies revealed higher phthalate esters concentra-
tions in women with endometriosis compared to controls the results of epidemio-
logical studies remain equivocal. Moreover, the short half-life of 5–6 h for these 
chemicals suggests that higher concentrations detected in women with endometrio-
sis compared to controls may be a consequence of the disease rather than a causal 
factor and thus reverse causation cannot be excluded. While in vitro studies suggest 
that phthalate esters can adversely affect mechanisms relevant to the pathophysiol-
ogy of endometriosis, the effective concentrations are beyond human exposure and 
thus are unlikely to be clinically important.
3.6 Metals
Trace metals are nearly impossible to avoid in one’s lifetime, as they are found 
both naturally in our bodies and are produced during industrial processes. Exposure 
to metals has been reported to interfere with cell proliferation, migration, cell 
degeneration, oxidative stress, and apoptosis, nearly all of which are properties of 
endometriosis [76]. Therefore, a link between circulating concentrations of metals 
and endometriosis has been explored by several groups.
A positive relationship between lead and endometriosis (adjusted OR = 2.59, 
95% CI = 1.11–6.06) was found in Asian women whereas zinc levels were inversely 
associated with the disease (adjusted OR = 0.39, 95% CI = 0.18–0.88) [77]. While 
cadmium (Cd) levels were greater in women with endometriosis, the adjusted odds 
ratio was not significant [77]. Furthermore, no significant relationship was found 
between 20 trace elements quantified in the urine and three in blood [76]. Cases 
were surgically confirmed, whereas the controls were confirmed for the absence 
of endometriosis through MRI. Contrary to the findings by [24], Cd was inversely 
related to endometriosis risk, while urinary chromium and copper were marginally 
associated with endometriosis (aOR = 1.97; 95% CI: 1.21–3.19; aOR = 2.66; 95% 
CI: 1.26–5.64) [76]. Comparisons for each of the metals increase the probability of 
chance discovery and thus any association is considered suspect.
Our search of the literature failed to reveal any recent animal studies; however, 
a tissue culture study revealed that Cd treatment-induced higher ESC proliferation 
(p = 0.02) in cultures derived from eutopic endometrium of women with endome-
triosis compared to controls [78]. Although the mechanism was not identified, it 
is suggested that Cd at 10−5 M is the toxic threshold for ESCs [78], a concentration 
that is orders of magnitude above typical human exposure.
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In summary, biomonitoring studies offer weak support for a potential link 
between metals exposure and endometriosis. Moreover, results from a tissue 
culture experiment suggest that Cd can adversely affect ESC proliferation but only 
at concentrations far in excess of human exposure. Consequently, we consider 
the evidence of a link between exposure to metals and risk of endometriosis to be 
speculative at best.
4. Future directions
The current literature fails to provide compelling evidence for an association 
between exposure to environmental toxicants and endometriosis risk. Although 
current evidence is weak, involvement of environmental toxicants in the patho-
physiology of endometriosis cannot be excluded. However, we propose that 
establishing a link between exposure to environmental toxicants and endometriosis 
is particularly challenging. Endometriosis is a heterogeneous disease in which 
peritoneal and ovarian endometriomas may arise by mechanisms that differ from 
DIE [79] and thus environmental interactions may be different from other forms of 
the disease.
Absence of diagnostic tools such as a blood test for endometriosis together with 
normalization of pelvic pain and use of oral contraceptives among other factors 
leads to lengthy delays in diagnosis. Importantly, the interval between the onset and 
symptoms and definitive diagnosis of disease can be lengthy varying between 6 and 
12 years [34]. Thus, there is a temporal disconnection between collection of biologi-
cal samples for analysis and the onset of disease. Hence, the use of case–control 
studies may not permit convincing evidence of an association and the potential for 
reverse causation cannot be excluded.
Identification of appropriate control groups poses an additional challenge 
since the prevalence of endometriosis in asymptomatic women can be high [1]. 
Furthermore, the hallmarks of endometriosis include chronic pelvic pain and infer-
tility. Women dealing with chronic pain and or infertility may adopt activities or 
behaviors to reduce their pain or improve their chances of conceiving that diverge 
from the healthy fertile population and thus their exposures may be a function of 
disease status rather than factors contributing to the pathophysiology of endome-
triosis. Consequently, in the absence of clinical tools to diagnosis endometriosis, the 
most appropriate control group in the future may be symptomatic women undergo-
ing laparoscopy with careful inspection of the pelvic cavity to exclude the presence 
of endometriosis, even though this step is admittedly imperfect [80].
Epidemiological studies that adjust for potential confounders (e.g. age, BMI, 
parity, breast feeding, cigarette smoking, and alcohol consumption) and account 
for multiple comparisons could prove valuable in elucidating the role of exposure 
to environmental toxicants in the pathophysiology of endometriosis. Finally, it 
is unlikely that any group of women are exposed to a singly chemical or group of 
chemicals and thus quantification of chemicals from different chemical groups in a 
single study with an appropriate control, control for confounds and correction for 
multiple comparisons could prove informative.
In the absences of robust epidemiological data experimental animal studies take 
on greater importance for establishing biological plausibility of a potential associa-
tion. In general, there is a paucity of literature addressing the potential hazards of 
environmental toxicants in the survival and growth of endometriotic implants in 
animal models of endometriosis. While spontaneous endometriosis is predomi-
nately limited to humans and some non-human primates, animal xenotransplant 
models using dispersed cells from ectopic implants in women with endometriosis 
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can provide valuable insight into potential chemical hazards relevant to endome-
triosis and mechanisms. However, dose levels used should include a concentration 
representative of human exposure. Similarly, tissue culture studies are essential 
for mechanistic insight; however, we propose that test concentrations should cover 
a range of doses that include concentrations below and representative of human 
exposure as well as high doses through to toxic levels.
5. Summary and conclusions
While in general, the epidemiological studies are judged to provide weak evi-
dence of an association between exposure to environmental toxicants and endome-
triosis, a potential link cannot be excluded. Animal and cell culture models suggest 
biologically plausible mechanisms between the environmental toxicant exposures 
and endometriosis risk; however, the effective concentrations exceed human expo-
sure levels. Consequently, we conclude that a causal relationship between exposure 
to any environmental toxicant and endometriosis does not currently exist, but the 
evidence does not allow us to exclude a potential link.
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